These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9163797)

  • 1. Polyglucose solutions in CAPD.
    Wilkie ME; Brown CB
    Perit Dial Int; 1997; 17 Suppl 2():S47-50. PubMed ID: 9163797
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient.
    Queffeulou G; Bernard M; Vrtovsnik F; Skhiri H; Lebrun-Vigne B; Hufnagel G; Michel C; Mignon F
    Clin Nephrol; 1999 Mar; 51(3):184-6. PubMed ID: 10099892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD; Gokal R; Peers E
    Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purple icodextrin: Turkish delight?
    Abrahams AC; Rutherford P; Boer WH
    Perit Dial Int; 2013; 33(4):445-7. PubMed ID: 23843590
    [No Abstract]   [Full Text] [Related]  

  • 6. Does peritoneal dialysis predispose a diabetic patient to icodextrin-induced peritonitis?
    Fiedler R; Schneider I; Buchmann J; Osten B; Langer T
    Nephrol Dial Transplant; 2002 Sep; 17(9):1708-9. PubMed ID: 12198234
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure.
    Goldsmith D; Jayawardene S; Sabharwal N; Cooney K
    Lancet; 2000 Mar; 355(9207):897. PubMed ID: 10752708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential hazards of polyglucose.
    Diaz-Buxo JA; Passlick-Deetjen J; Gotloib L
    ASAIO J; 2001; 47(6):602-7. PubMed ID: 11730195
    [No Abstract]   [Full Text] [Related]  

  • 9. Icodextrin allergy in a peritoneal dialysis patient.
    Fletcher S; Stables GA; Turney JH
    Nephrol Dial Transplant; 1998 Oct; 13(10):2656-8. PubMed ID: 9794582
    [No Abstract]   [Full Text] [Related]  

  • 10. Icodextrin hypersensitivity in a CAPD patient.
    Lam-Po-Tang MK; Bending MR; Kwan JT
    Perit Dial Int; 1997; 17(1):82-4. PubMed ID: 9068028
    [No Abstract]   [Full Text] [Related]  

  • 11. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin-associated peritonitis among CAPD patients.
    Seow YY; Iles-Smith H; Hirst H; Gokal R
    Nephrol Dial Transplant; 2003 Sep; 18(9):1951-2. PubMed ID: 12937264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterile chemical peritonitis secondary to icodextrin: immunohistopathological description.
    Goffin E; Tintillier M; Cosyns JP; Devuyst O
    Perit Dial Int; 2002; 22(6):723-6. PubMed ID: 12556077
    [No Abstract]   [Full Text] [Related]  

  • 15. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient.
    Del Rosso G; Di Liberato L; Perilli A; Cappelli P; Bonomini M
    Nephrol Dial Transplant; 2000 Jun; 15(6):927-8. PubMed ID: 10831669
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient sterile chemical peritonitis in a CAPD patient using icodextrin.
    Goffin E; Scheiff JM
    Perit Dial Int; 2002; 22(1):90-1. PubMed ID: 11929151
    [No Abstract]   [Full Text] [Related]  

  • 18. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
    Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
    J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.